Xtramed International launched a new advanced Research & Development (R&D) unit to strengthen its formulation capabilities in the wellness and healthcare sectors.
This expansion enhances the company’s ability to develop innovative, science-based formulations tailored to market needs and regulatory standards. The new unit supports faster product development, improved formulation stability, and higher quality control across supplements and health-related products.
This milestone reflects Xtramed’s continued investment in innovation and its commitment to delivering advanced, market-ready solutions for its partners.